Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= GBA ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: GBA * **<color #00a2e8>Official Name</color>**: glucosylceramidase beta * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2629|2629]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P04062|P04062]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=GBA&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GBA|Open PubMed]] * **<color #00a2e8>OMIM</color>**: N/A == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]. * **<color #00a2e8>UniProt Summary</color>**: N/A <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Glyco hydro 30| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |positive regulation of neuronal action potential| |beta-glucoside catabolic process| |steryl-beta-glucosidase activity| |beta-glucoside metabolic process| |termination of signal transduction| |glucosylceramidase activity| |glucosylceramide catabolic process| |positive regulation of protein lipidation| |scavenger receptor binding| |regulation of neuronal action potential| |positive regulation of lipoprotein metabolic process| |regulation of protein lipidation| |glucosyltransferase activity| |glucosylceramide metabolic process| |glycosylceramide catabolic process| |positive regulation of transmission of nerve impulse| |regulation of lysosomal protein catabolic process| |skin morphogenesis| |positive regulation of action potential| |regulation of protein catabolic process in the vacuole| |glycoside catabolic process| |negative regulation of protein homooligomerization| |sphingosine biosynthetic process| |positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization| |lipid glycosylation| |sphingoid biosynthetic process| |sphingosine metabolic process| |regulation of autophagy of mitochondrion in response to mitochondrial depolarization| |glycosphingolipid catabolic process| |regulation of lipoprotein metabolic process| |glycolipid catabolic process| |sphingoid metabolic process| |negative regulation of protein oligomerization| |regulation of transmission of nerve impulse| |glycosylceramide metabolic process| |diol biosynthetic process| |positive regulation of autophagy of mitochondrion| |ceramide catabolic process| |response to mitochondrial depolarisation| |regulation of protein homooligomerization| |cell death in response to oxidative stress| |diol metabolic process| |glycoside metabolic process| |regulation of water loss via skin| |response to thyroid hormone| |sphingolipid catabolic process| |membrane lipid catabolic process| |positive regulation of protein complex disassembly| |response to testosterone| |response to dexamethasone| |response to pH| |regulation of autophagy of mitochondrion| |negative regulation of interleukin-6 production| |regulation of protein oligomerization| |positive regulation of protein dephosphorylation| |glycosyl compound catabolic process| |ceramide biosynthetic process| |regulation of action potential| |positive regulation of dephosphorylation| |lysosome organization| |polyol biosynthetic process| |lytic vacuole organization| |positive regulation of nervous system process| |glycosphingolipid metabolic process| |autophagosome organization| |extrinsic component of membrane| |multicellular organismal water homeostasis| |water homeostasis| |negative regulation of MAP kinase activity| |response to estrogen| |hydrolase activity| |positive regulation of proteasomal ubiquitin-dependent protein catabolic process| |ceramide metabolic process| |sphingolipid biosynthetic process| |lysosomal lumen| |response to antineoplastic agent| |positive regulation of ubiquitin-dependent protein catabolic process| |regulation of TOR signaling| |positive regulation of proteasomal protein catabolic process| |glycolipid metabolic process| |liposaccharide metabolic process| |polyol metabolic process| |alcohol biosynthetic process| |regulation of protein complex disassembly| |positive regulation of mitochondrion organization| |cholesterol metabolic process| |positive regulation of proteolysis involved in cellular protein catabolic process| |positive regulation of autophagy| |regulation of proteasomal ubiquitin-dependent protein catabolic process| |secondary alcohol metabolic process| |vacuole organization| |membrane lipid biosynthetic process| |negative regulation of protein complex assembly| |negative regulation of protein serine/threonine kinase activity| |glycosyl compound metabolic process| |sterol metabolic process| |negative regulation of inflammatory response| |regulation of nervous system process| |regulation of interleukin-6 production| |regulation of protein dephosphorylation| |positive regulation of cellular protein catabolic process| |response to glucocorticoid| |cellular response to starvation| |regulation of ubiquitin-dependent protein catabolic process| |sphingolipid metabolic process| |macroautophagy| |response to corticosteroid| |negative regulation of MAPK cascade| |trans-Golgi network| |regulation of macroautophagy| |regulation of mitochondrion organization| |regulation of proteasomal protein catabolic process| |organic hydroxy compound biosynthetic process| |carbohydrate derivative catabolic process| |response to starvation| |response to ketone| |ammonium ion metabolic process| |cellular lipid catabolic process| |lipid modification| |membrane lipid metabolic process| |negative regulation of neuron death| |negative regulation of defense response| |regulation of dephosphorylation| |positive regulation of protein catabolic process| |regulation of proteolysis involved in cellular protein catabolic process| |negative regulation of protein kinase activity| |cellular response to nutrient levels| |cellular response to oxidative stress| |cellular response to tumor necrosis factor| |negative regulation of kinase activity| |regulation of cellular protein catabolic process| |lysosome| |steroid metabolic process| |process utilizing autophagic mechanism| |autophagy| |response to tumor necrosis factor| |cellular response to extracellular stimulus| |glycosylation| |negative regulation of cytokine production| |negative regulation of transferase activity| |lipid catabolic process| |response to xenobiotic stimulus| |lysosomal membrane| |regulation of neuron death| |alcohol metabolic process| |multicellular organismal homeostasis| |response to steroid hormone| |regulation of autophagy| |signaling receptor binding| |cellular response to external stimulus| |regulation of inflammatory response| |regulation of MAP kinase activity| |positive regulation of proteolysis| |positive regulation of cellular catabolic process| |negative regulation of response to external stimulus| |skin development| |regulation of protein catabolic process| |response to oxidative stress| |negative regulation of protein phosphorylation| |regulation of membrane potential| |positive regulation of catabolic process| |mitochondrion organization| |negative regulation of phosphorylation| |regulation of protein complex assembly| |organic hydroxy compound metabolic process| |regulation of body fluid levels| |response to nutrient levels| |negative regulation of intracellular signal transduction| |regulation of protein serine/threonine kinase activity| |amide biosynthetic process| |response to extracellular stimulus| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |regulation of system process| |negative regulation of protein modification process| |positive regulation of organelle organization| |neuron projection development| |regulation of cytokine production| |negative regulation of cellular component organization| |regulation of proteolysis| |regulation of MAPK cascade| |regulation of defense response| |cellular amide metabolic process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |neuron development| |regulation of cellular catabolic process| |response to lipid| |regulation of kinase activity| |response to hormone| |response to organic cyclic compound| |animal organ morphogenesis| |cellular lipid metabolic process| |regulation of cellular component biogenesis| |regulation of transferase activity| |Golgi apparatus| |negative regulation of cell death| |regulation of catabolic process| |cellular response to cytokine stimulus| |neuron differentiation| |endoplasmic reticulum| |response to drug| |carbohydrate derivative metabolic process| |negative regulation of cellular protein metabolic process| |organonitrogen compound catabolic process| |cell death| |regulation of response to external stimulus| |response to cytokine| |negative regulation of protein metabolic process| |chemical homeostasis| |plasma membrane bounded cell projection organization| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of molecular function| |response to abiotic stimulus| |cell projection organization| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |lipid metabolic process| |positive regulation of protein modification process| |negative regulation of signal transduction| |regulation of organelle organization| |negative regulation of cell communication| |negative regulation of signaling| |organonitrogen compound biosynthetic process| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of response to stress| |generation of neurons| |response to oxygen-containing compound| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |neurogenesis| |cellular nitrogen compound biosynthetic process| |homeostatic process| |cell development| |regulation of cell death| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |small molecule metabolic process| |organic substance catabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.73| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 9396 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 5.76 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='GBA Expression in NALM6 Cells: 5.76'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:36by 127.0.0.1